Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 1/20 | 0.93 |
| ▸ | LMNA | P02545 | 1/20 | 0.93 |
| ▸ | PGR | P06401 | 1/20 | 0.93 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | FNTA | P49354 | 1/20 | 0.47 |
| ▸ | FNTB | P49356 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.42 |
| ▸ | SQLE | Q14534 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2067023 | 1.00 | NR1I2 (0.93) | NR1I2LMNAPGRALDH1A1KMT2A | |
| SCHEMBL7106183 | 1.00 | NR1I2 (0.93) | NR1I2LMNAPGRALDH1A1KMT2A | |
| SCHEMBL2835876 | 0.96 | NR1I2 (0.86) | NR1I2LMNAPGRALDH1A1KMT2A | |
| Lycopene SCHEMBL38650730 | 0.96 | NR1I2 (1.00) | NR1I2LMNAPGRALDH1A1KMT2A | |
| Lycopene SCHEMBL29401313 | 0.96 | NR1I2 (1.00) | NR1I2LMNAPGRALDH1A1KMT2A | |
| Lycopene SCHEMBL20158 | 0.96 | NR1I2 (1.00) | NR1I2LMNAPGRALDH1A1KMT2A | |
| SCHEMBL2833787 | 0.96 | NR1I2 (1.00) | NR1I2LMNAPGRALDH1A1KMT2A | |
| Lycopene SCHEMBL21485499 | 0.96 | NR1I2 (1.00) | NR1I2LMNAPGRALDH1A1KMT2A | |
| Lycopene SCHEMBL30272252 | 0.96 | NR1I2 (1.00) | NR1I2LMNAPGRALDH1A1KMT2A | |
| Lycopene SCHEMBL30471634 | 0.96 | NR1I2 (1.00) | NR1I2LMNAPGRALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1476546-A2 | FUNCTIONALIZATION OF CAROTENOID COMPOUNDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-11-17 | — | — | EP | claimed |
| US-20030182687-A1 | Functionalization of carotenoid compounds | E.I. DU PONT DE NEMOURS AND COMAPANY | 2003-09-25 | — | — | US | claimed |
| WO-2003068917-A2 | FUNCTIONALIZATION OF CAROTENOID COMPOUNDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-08-21 | — | — | WO | claimed |
| US-11781148-B2 | Biological methods for preparing terpenes | RADICI CHIMICA S.P.A. (IT) | 2023-10-10 | — | — | US | disclosed |
| US-11332724-B2 | Microbial production of terpenoids | DSM IP ASSETS B.V. (NL) | 2022-05-17 | — | — | US | disclosed |
| US-20180148697-A1 | MICROBIAL PRODUCTION OF TERPENOIDS | DSM IP ASSETS B.V. (NL) | 2018-05-31 | — | — | US | disclosed |
| US-9909130-B2 | Production of carotenoids in oleaginous yeast and fungi | DSM IP ASSETS B.V. (NL) | 2018-03-06 | — | — | US | disclosed |
| EP-3286303-A1 | MICROBIAL PRODUCTION OF TERPENOIDS | DSM IP Assets B.V. (NL) | 2018-02-28 | — | — | EP | disclosed |
| WO-2016172282-A1 | MICROBIAL PRODUCTION OF TERPENOIDS | DSM IP ASSETS B.V. (NL) | 2016-10-27 | — | — | WO | disclosed |
| US-9297031-B2 | Production of carotenoids in oleaginous yeast and fungi | DSM IP ASSETS B.V. (NL) | 2016-03-29 | — | — | US | disclosed |
| EP-2371967-B1 | Production of carotenoids in oleaginous yeast and fungi | DSM IP ASSETS BV (NL) | 2015-06-03 | — | — | EP | disclosed |
| US-20050221467-A1 | Biological production of tetradehydrolycopene | E. I. DU PONT DE NEMOURS AND COMPANY | 2005-10-06 | — | — | US | disclosed |
| WO-2005047486-A2 | BIOLOGICAL PRODUCTION OF TETRADEHYDROLYCOPENE | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2005-05-26 | — | — | WO | disclosed |
| EP-1476546-A2 | FUNCTIONALIZATION OF CAROTENOID COMPOUNDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-11-17 | — | — | EP | disclosed |
| US-20030182687-A1 | Functionalization of carotenoid compounds | E.I. DU PONT DE NEMOURS AND COMAPANY | 2003-09-25 | — | — | US | disclosed |
| WO-2003068917-A2 | FUNCTIONALIZATION OF CAROTENOID COMPOUNDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-08-21 | — | — | WO | disclosed |
| EP-1238068-A1 | DIRECTED EVOLUTION OF BIOSYNTHETIC AND BIODEGRATION PATHWAYS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2002-09-11 | — | — | EP | disclosed |
| WO-2001042455-A9 | DIRECTED EVOLUTION OF BIOSYNTHETIC AND BIODEGRATION PATHWAYS | CALIFORNIA INST OF TECHN (US) | 2002-05-30 | — | — | WO | disclosed |
| US-20020051998-A1 | Directed evolution of biosynthetic and biodegradation pathways | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2002-05-02 | — | — | US | disclosed |
| WO-2001042455-A1 | DIRECTED EVOLUTION OF BIOSYNTHETIC AND BIODEGRATION PATHWAYS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2001-06-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030182687-A1 | Functionalization of carotenoid compounds | FASN, ALOX12, ADH1A | NR1I2 430/4885LMNA 1019/4885PGR 3873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.